Literature DB >> 29931217

Estimating and Interpreting the Overall Survival Benefit of Checkpoint Inhibitors via Meta-analysis-Reply.

Val Gebski1, James Chih-Hsin Yang2,3, Chee Khoon Lee1,4.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29931217     DOI: 10.1001/jamaoncol.2018.1105

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  2 in total

1.  Methods for Accommodating Nonproportional Hazards in Clinical Trials: Ready for the Primary Analysis?

Authors:  Boris Freidlin; Edward L Korn
Journal:  J Clin Oncol       Date:  2019-10-24       Impact factor: 44.544

2.  Time-dependent treatment effects of metronomic chemotherapy in unfit AML patients: a secondary analysis of a randomised controlled trial.

Authors:  Phichayut Phinyo; Jayanton Patumanond; Saranya Pongudom
Journal:  BMC Res Notes       Date:  2021-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.